Fenofibric Acid

CHEBI:CHEBI_747808

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

nui
N0000175596
pharm_class_epc
Peroxisome Proliferator Receptor alpha Agonist [EPC]
pharm_class
Peroxisome Proliferator Receptor alpha Agonist [EPC]
active_ingredient_strength
135 mg/1
active_ingredient_name
CHOLINE FENOFIBRATE
upc
0301151325104
spl_set_id
af225492-73b0-49bb-b32f-5399c3c3ec6d
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
route
ORAL
dosage_form
CAPSULE, DELAYED RELEASE
marketing_start_date
20131204
labeler_name
Graviti Pharmaceuticals Private Limited
generic_name
Fenofibric acid
brand_name
Trilipix
brand_name_base
Trilipix
product_ndc
0115-1554
spl_id
5e87f392-e6ca-4aa5-ad20-005fb01b22d1
package_ndc
0115-1554-10
application_number
ANDA200264
rxcui
828381
package_marketing_start_date
20170518
manufacturer_name
Graviti Pharmaceuticals Private Limited
package_description
90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0115-1554-10)
unii
4BMH7IZT98